Breast cancer

Indication for Megestrol

Population group: Suitable for women, only adults (18 years old or older)

Megestrol is a progestational agent, indicated for the treatment of certain hormone dependent neoplasms, such as breast cancer.

For this indication, competent medicine agencies globally authorize below treatments:

160 mg once daily

Route of admnistration

Oral

Defined daily dose

160 - 160 mg

Dosage regimen

From 160 To 160 mg once every day

Detailed description

160 mg/day taken once daily.

At least two months of continuous treatment is considered an adequate period for determining the efficacy of megestrol.

Active ingredient

Megestrol possesses pharmacological properties similar to those of natural progesterone. Megestrol acetate is a potent progestogen that exerts significant anti-oestrogenic effects. It has no androgenic or oestrogenic properties.

Read more about Megestrol

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner